Search research articles
Contact Us
Filters
Showing results (301-310 of 357) with videos related to
Page
of 36
Sort By:
Jac-Antimicrobial Resistance
|
May 13, 2026
Clinical implications of cefoperazone-sulbactam MIC values in <i>Pseudomonas aeruginosa</i> bloodstream infections: a multicentre study
Shian-Sen Shie, Ting-Shu Wu, Feng-Yee Chang, et al.
The Lancet. Oncology
|
February 13, 2022
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Paul G Richardson, Aurore Perrot, Jesus San-Miguel, et al.
British Journal of Haematology
|
December 23, 2016
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
Noopur S Raje, Philippe Moreau, Evangelos Terpos, et al.
Infectious Diseases and Therapy
|
July 21, 2022
Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli Bacteremia
Shang-Yi Lin, Po-Liang Lu, Ting-Shu Wu, et al.
British Journal of Haematology
|
March 29, 2019
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
Jia-Hau Liu, Xiu-Wen Liao, Chien-Hung Chen, et al.
Cell Reports
|
February 3, 2015
Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation
Chun-Ting Lee, Raphael M Bendriem, Abigail A Kindberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 12, 2024
Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment
Tsung-Ta Chiang, Ming-Hsien Chiang, Hung-Jen Tang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 18, 2025
High co-infection burden and ICU-specific pathogen profiles in pediatric Candida albicans respiratory infections: a large-scale tNGS analysis
Ya Huang, Huideng Zhou, Jiangyang Zhao, et al.
European Journal of Human Genetics : EJHG
|
August 20, 2009
Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis
Ming-Wei Lin, Ding-Dar Lee, Tze-Tze Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
Kazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 357) with videos related to
Sort By:
Page
of 36
Jac-Antimicrobial Resistance
|
May 13, 2026
Clinical implications of cefoperazone-sulbactam MIC values in <i>Pseudomonas aeruginosa</i> bloodstream infections: a multicentre study
Shian-Sen Shie, Ting-Shu Wu, Feng-Yee Chang, et al.
The Lancet. Oncology
|
February 13, 2022
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Paul G Richardson, Aurore Perrot, Jesus San-Miguel, et al.
British Journal of Haematology
|
December 23, 2016
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
Noopur S Raje, Philippe Moreau, Evangelos Terpos, et al.
Infectious Diseases and Therapy
|
July 21, 2022
Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli Bacteremia
Shang-Yi Lin, Po-Liang Lu, Ting-Shu Wu, et al.
British Journal of Haematology
|
March 29, 2019
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
Jia-Hau Liu, Xiu-Wen Liao, Chien-Hung Chen, et al.
Cell Reports
|
February 3, 2015
Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation
Chun-Ting Lee, Raphael M Bendriem, Abigail A Kindberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 12, 2024
Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment
Tsung-Ta Chiang, Ming-Hsien Chiang, Hung-Jen Tang, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 18, 2025
High co-infection burden and ICU-specific pathogen profiles in pediatric Candida albicans respiratory infections: a large-scale tNGS analysis
Ya Huang, Huideng Zhou, Jiangyang Zhao, et al.
European Journal of Human Genetics : EJHG
|
August 20, 2009
Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis
Ming-Wei Lin, Ding-Dar Lee, Tze-Tze Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
Kazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Page
of 36